12:26
2026-07-14
machinebrief.com
artificial-intelligence
Drug Discovery: How Vilya-1 is Shaping the Future of Macrocyclic Peptides
Vilya-1, a new deep learning model for macrocyclic peptide design, improves geometric accuracy and chemical coverage over traditional methods, enabling generative applications for custom therapeutics.โฆ